XOMA Corporation

Historical 13F Holders

Symbol
XOMA
CUSIP
98419J206
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 98419J206 since 12/18/2024, largest first.

Filer % of Class Filed
Ligand Pharmaceuticals Inc 13D 47.0% 5/1/2026
Event 4/27/2026
Woodline Partners LP 13G 5.4% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
BlackRock, Inc. 13G/A 3.9% 7/30/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G/A 3.2% 7/31/2026
Event 6/30/2026
Biotechnology Value Fund L P 13D/A
0% 7/16/2026
Event 7/14/2026
FMR LLC 13G/A
0% 8/7/2026
Event 7/31/2026
Morgan Stanley 13G/A
0% 8/7/2026
Event 7/31/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 109 17.0 M $724 M
2026 Q1 89 9.99 M $313 M
2025 Q4 75 8.66 M $231 M
2025 Q3 75 8.33 M $321 M
2025 Q2 68 8.18 M $206 M
2025 Q1 68 7.85 M $156 M
2024 Q4 68 7.82 M $205 M
2024 Q3 71 7.70 M $203 M
2024 Q2 65 7.85 M $185 M
2024 Q1 64 7.93 M $191 M
2023 Q4 64 7.53 M $139 M
2023 Q3 56 7.64 M $108 M
2023 Q2 61 7.62 M $139 M
2023 Q1 53 7.05 M $149 M
2022 Q4 53 6.64 M $122 M
2022 Q3 48 6.28 M $113 M
2022 Q2 49 6.23 M $139 M
2022 Q1 56 6.37 M $178 M
2021 Q4 55 6.40 M $133 M
2021 Q3 50 6.33 M $157 M
2021 Q2 54 6.29 M $214 M
2021 Q1 63 6.37 M $260 M
2020 Q4 62 6.44 M $284 M
2020 Q3 57 6.32 M $119 M
2020 Q2 59 6.30 M $124 M
2020 Q1 51 4.81 M $98.0 M
2019 Q4 57 4.62 M $126 M
2019 Q3 48 3.27 M $64.1 M
2019 Q2 53 3.92 M $58.2 M
2019 Q1 52 4.17 M $51.7 M
2018 Q4 54 4.27 M $53.8 M
2018 Q3 63 3.61 M $63.4 M
2018 Q2 65 3.66 M $76.4 M
2018 Q1 59 3.40 M $69.1 M
2017 Q4 58 3.24 M $115 M
2017 Q3 35 2.73 M $53.6 M
2017 Q2 31 2.50 M $17.5 M
2017 Q1 35 2.37 M $16.8 M
2016 Q4 45 1.10 M $4.63 M
2016 Q3 2 30.7 k $14.0 k